Role of Gut Microbiome in Cancer Therapy

Part of paid clinical trials in Scottsdale, Arizona.

Sponsor
Mayo Clinic
Study ID
NCT05112614
Status
Recruiting
Apply to this trial

Conditions

  • Hematopoietic and Lymphoid Cell Neoplasm
  • Malignant Solid Neoplasm

Eligibility Criteria

Sex
ALL
Age
18 Years - 99 Years
Healthy Volunteers
Not accepted

Interventions

  • Biospecimen Collection — PROCEDURE
    Undergo collection of blood and stool samples
  • Electronic Health Record Review — OTHER
    Review of medical records

Study Details

This study examines how gut microbiome can affect cancer therapy in cancer patients undergoing cancer therapy or stem cell transplant. The human microbiome affects the way some cancer drugs are metabolized in the human body. Information from this study may help doctors improve the way cancer treatment is delivered, and increase its effectiveness and success.

Key Dates

Start date
Sep 11, 2019
Status verified
Mar 2026
Primary completion
Oct 1, 2030
Completion
Oct 1, 2030

Study Design

Enrollment
3,000 participants (estimated)

Arms

  • Arm: Observational (biospecimen collection, medical record review)
    Patients undergo collection of blood and stool samples and have their medical records reviewed.

Primary Outcome Measure

Gut microbiome associations with cancer diagnoses [ Time Frame: Through study completion, average of 1 year ]

Central Contacts

Locations (3)

FacilityCityStateZIPSite coordinators
Mayo Clinic in ArizonaScottsdaleArizona85259-
Mayo Clinic in FloridaJacksonvilleFlorida32224-
Mayo Clinic in RochesterRochesterMinnesota55905
Clinical Trials Referral Office
[email protected]
855-776-0015
Purna C. Kashyap, MBBS (PRINCIPAL_INVESTIGATOR)

Find similar trials in Scottsdale, AZ

By research site
Mayo Clinic in Arizona· Scottsdale, AZMayo Clinic in Florida· Jacksonville, FLMayo Clinic in Rochester· Rochester, MN

Related Studies